Amrutanjan Health Care Limited
NSE: AMRUTANJAN BSE: AMRUTANJAN
NSE
600.05
-2.85 (-0.47%)
Prev Close
602.9
Open Price
605.9
Volume
9,350
Today Low / High
599.2 / 610.9
52 WK Low / High
544.1 / 790.95
Range
570 - 630
BSE
598.10
-7.60 (-1.25%)
Prev Close
605.7
Open Price
590.85
Volume
1,163
Today Low / High
590.85 / 606.75
52 WK Low / High
548.05 / 789.95
Range
568 - 628
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 600.05 (target range: 570 - 630), reflecting a change of -2.85 (-0.47272%). On the BSE, it is listed at 598.1 (target range: 568 - 628), showing a change of -7.6 (-1.25475%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
25 Feb
605.90
-0.97%
24 Feb
606.75
-0.63%
23 Feb
619.30
-2.52%
20 Feb
618.30
-0.33%
19 Feb
629.55
-2.45%
18 Feb
616.00
2.20%
17 Feb
606.00
0.96%
16 Feb
627.65
-3.25%
13 Feb
636.60
-0.09%
12 Feb
642.20
-0.87%
11 Feb
635.60
2.01%
10 Feb
634.95
0.53%
09 Feb
635.00
-0.35%
06 Feb
629.00
0.80%
05 Feb
638.00
-1.31%
04 Feb
593.20
7.05%
03 Feb
584.60
-0.33%
02 Feb
570.10
0.80%
01 Feb
583.75
-1.39%
30 Jan
577.40
1.10%
29 Jan
590.00
-1.46%
28 Jan
595.75
-1.23%
Amrutanjan Health Care Limited Graph
Amrutanjan Health Care Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Amrutanjan Health Care Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 600.05, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 598.10 | 604.08 | 543.67 - 664.49 |
| 610.06 | 488.05 - 732.07 | ||
| 616.04 | 431.23 - 800.86 | ||
| Bearish Scenario | 598.10 | 592.12 | 532.91 - 651.33 |
| 586.14 | 468.91 - 703.37 | ||
| 580.16 | 406.11 - 754.20 |
Overview of Amrutanjan Health Care Limited
ISIN
INE098F01031
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
13,205
Market Cap
17,341,493,604
Last Dividend
4.6
Official Website
IPO Date
2009-11-05
DCF Diff
167.68
DCF
462
Financial Ratios Every Investor Needs
Stock Dividend of AMRUTANJAN
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2026-02-06 | February 06, 26 | 1 | 1 | 2026-02-07 | 2026-03-05 | |
| 2025-11-18 | November 18, 25 | 1 | 1 | 2025-11-18 | 2025-12-10 | |
| 2025-09-16 | September 16, 25 | 2.6 | 2.6 | 2025-09-16 | 2025-10-23 | |
| 2025-02-18 | February 18, 25 | 1 | 1 | 2025-02-18 | 2025-03-14 | |
| 2024-11-22 | November 22, 24 | 1 | 1 | 2024-11-22 | 2024-12-12 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 450.51 Cr | 223.21 Cr | 246.29 Cr | 0.5467 | 0.00 Cr | 59.10 Cr | 54.59 Cr | 50.83 Cr | 17.58 | 75.88 Cr | 0.1128 |
| 2024-03-31 | 421.23 Cr | 275.61 Cr | 145.62 Cr | 0.3457 | 0.00 Cr | 5.20 Cr | 48.72 Cr | 44.97 Cr | 15.50 | 68.16 Cr | 0.1068 |
| 2023-03-31 | 379.54 Cr | 181.98 Cr | 197.56 Cr | 0.5205 | 1.20 Cr | 4.46 Cr | 41.85 Cr | 39.83 Cr | 13.65 | 59.08 Cr | 0.1050 |
| 2022-03-31 | 405.45 Cr | 180.46 Cr | 224.98 Cr | 0.5549 | 1.13 Cr | 2.73 Cr | 79.84 Cr | 67.19 Cr | 23.00 | 94.70 Cr | 0.1657 |
| 2021-03-31 | 331.55 Cr | 140.19 Cr | 191.36 Cr | 0.5772 | 0.87 Cr | 2.44 Cr | 71.79 Cr | 61.19 Cr | 20.94 | 86.17 Cr | 0.1846 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 83.16 Cr | 421.39 Cr | 94.77 Cr | 326.6146 Cr | 2.08 Cr | -81.08 Cr | 27.26 Cr | 63.93 Cr | 1.23 Cr | 0.00 Cr | 41.70 Cr | 84.5832 Cr |
| 2024-03-31 | 25.76 Cr | 366.87 Cr | 78.38 Cr | 288.4883 Cr | 1.73 Cr | -24.04 Cr | 28.90 Cr | 49.54 Cr | 1.06 Cr | 0.00 Cr | 11.78 Cr | 69.9185 Cr |
| 2023-03-31 | 4.90 Cr | 362.09 Cr | 71.32 Cr | 290.7719 Cr | 0.91 Cr | -3.99 Cr | 28.83 Cr | 47.55 Cr | 7.22 Cr | -1.77 Cr | 0.06 Cr | 63.0121 Cr |
| 2022-03-31 | 83.48 Cr | 349.87 Cr | 84.74 Cr | 265.1238 Cr | 0.88 Cr | -82.60 Cr | 26.00 Cr | 43.47 Cr | 9.95 Cr | -1.70 Cr | 5.44 Cr | 77.4730 Cr |
| 2021-03-31 | 130.70 Cr | 274.27 Cr | 58.71 Cr | 215.5647 Cr | 1.34 Cr | -129.36 Cr | 17.46 Cr | 23.32 Cr | 0.00 Cr | -1.80 Cr | -24.48 Cr | 52.1034 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 50.8992 Cr | -30.9664 Cr | -13.4896 Cr | 15.3463 Cr | 6.4432 Cr | 10.1552 Cr | -35.5529 Cr | 50.8347 Cr | -0.4609 Cr | -13.2665 Cr | 1.6449 Cr |
| 2024-03-31 | 27.9106 Cr | 19.1650 Cr | -48.2664 Cr | 21.1929 Cr | -1.1908 Cr | 3.7120 Cr | -6.7177 Cr | 44.9726 Cr | -0.5572 Cr | -13.3863 Cr | -0.0796 Cr |
| 2023-03-31 | 19.2181 Cr | -2.4750 Cr | -14.0265 Cr | 10.2914 Cr | 2.7166 Cr | 4.9028 Cr | -8.9267 Cr | 53.6454 Cr | -0.5803 Cr | -14.4091 Cr | -2.8244 Cr |
| 2022-03-31 | 52.1956 Cr | -36.2119 Cr | -16.7024 Cr | 28.7322 Cr | -0.7189 Cr | 2.1862 Cr | -23.4634 Cr | 90.5766 Cr | -0.6920 Cr | -12.4765 Cr | -8.5421 Cr |
| 2021-03-31 | 89.7629 Cr | -87.7608 Cr | -6.2834 Cr | 87.8022 Cr | -4.3155 Cr | 2.9051 Cr | -1.9607 Cr | 81.9045 Cr | -0.6423 Cr | -4.6770 Cr | 6.2573 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 141.04 Cr | 81.57 Cr | 59.47 Cr | 0.4217 | 23.54 Cr | 19.45 Cr | 6.73 | 28.04 Cr | 0.1379 |
| 2025-09-30 | 117.70 Cr | 57.66 Cr | 60.05 Cr | 0.5102 | 14.97 Cr | 13.96 Cr | 4.83 | 20.82 Cr | 0.1186 |
| 2025-06-30 | 94.05 Cr | 49.39 Cr | 44.66 Cr | 0.4748 | 6.92 Cr | 8.31 Cr | 2.87 | 12.87 Cr | 0.0884 |
| 2025-03-31 | 135.56 Cr | 68.99 Cr | 71.24 Cr | 0.5255 | 18.99 Cr | 15.18 Cr | 5.25 | 22.53 Cr | 0.1120 |
| 2024-12-31 | 122.75 Cr | 55.80 Cr | 66.95 Cr | 0.5454 | 21.68 Cr | 19.25 Cr | 6.66 | 27.71 Cr | 0.1568 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 5.15 Cr | 202.31 Cr | 207.46 Cr | 38.30 Cr | 35.50 Cr | 292.17 Cr | 73.53 Cr | 432.36 Cr | 90.29 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 199.33 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -326.61 Cr |
| 2025-03-31 | 83.16 Cr | 0.00 Cr | 83.16 Cr | 55.82 Cr | 27.26 Cr | 290.67 Cr | 63.93 Cr | 421.39 Cr | 94.77 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 229.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -297.79 Cr |
| 2024-09-30 | 7.07 Cr | 222.30 Cr | 229.37 Cr | 34.63 Cr | 32.63 Cr | 305.60 Cr | 49.14 Cr | 382.60 Cr | 84.81 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 8.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 15.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 19.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 11.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 4.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2018-04-13 | April 13, 18 | 2:1 |
| 2012-10-25 | October 25, 12 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,764.20 | ₹4,232,906,754,074.00 | ₹1,200,910.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,395.50 | ₹1,697,804,303,390.00 | ₹348,437.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,418.90 | ₹1,495,556,554,816.00 | ₹359,909.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,306.50 | ₹1,087,750,340,235.00 | ₹2,296,180.00 |
| Lupin Limited | LUPIN | ₹2,292.20 | ₹1,047,633,964,600.00 | ₹1,104,211.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹919.65 | ₹925,383,088,904.00 | ₹564,412.00 |
| Mankind Pharma Limited | MANKIND | ₹2,155.70 | ₹889,883,893,710.00 | ₹802,349.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,211.50 | ₹703,641,166,265.00 | ₹3,039,172.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,625.00 | ₹672,553,125,000.00 | ₹231,439.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,085.00 | ₹588,388,686,765.00 | ₹455,450.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,076.35 | ₹581,074,632,036.00 | ₹2,096,370.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,524.50 | ₹386,772,080,341.00 | ₹102,371.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹3,021.30 | ₹377,468,000,791.00 | ₹185,671.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,085.90 | ₹334,844,408,201.00 | ₹172,351.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,430.80 | ₹271,240,390,232.00 | ₹90,076.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,377.10 | ₹223,767,965,930.00 | ₹212,770.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,869.00 | ₹221,725,000,000.00 | ₹2,566.00 |
| Eris Lifesciences Limited | ERIS | ₹1,380.20 | ₹188,006,552,958.00 | ₹30,161.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹978.20 | ₹175,205,274,834.00 | ₹5,721,405.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,331.00 | ₹171,035,250,259.00 | ₹27,190.00 |
| Granules India Limited | GRANULES | ₹599.95 | ₹145,589,096,164.00 | ₹775,187.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹739.90 | ₹145,437,055,448.00 | ₹143,343.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹897.35 | ₹142,113,093,368.00 | ₹305,229.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,727.00 | ₹131,272,198,992.00 | ₹21,410.00 |
| Cohance Lifesciences Limited | COHANCE | ₹310.50 | ₹118,787,096,970.00 | ₹467,931.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹907.55 | ₹111,389,056,800.00 | ₹41,715.00 |
| Viyash Scientific Limited | VIYASH | ₹219.27 | ₹95,646,792,922.00 | ₹684,479.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,136.00 | ₹85,254,425,952.00 | ₹7,919.00 |
| Strides Pharma Science Limited | STAR | ₹863.60 | ₹79,600,355,810.00 | ₹85,803.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹478.65 | ₹73,282,300,062.00 | ₹136,589.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹708.30 | ₹64,205,475,507.00 | ₹171,833.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹327.45 | ₹64,043,265,649.00 | ₹194,387.00 |
| FDC Limited | FDC | ₹364.30 | ₹59,311,713,601.00 | ₹46,671.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹130.92 | ₹42,486,366,301.00 | ₹619,172.00 |
| Innova Captab Limited | INNOVACAP | ₹668.35 | ₹38,246,281,297.00 | ₹12,022.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹316.30 | ₹34,465,713,320.00 | ₹32,182.00 |
| Suven Life Sciences Limited | SUVEN | ₹149.76 | ₹34,066,506,240.00 | ₹112,567.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹369.70 | ₹33,742,519,000.00 | ₹60,664.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹630.60 | ₹31,983,467,613.00 | ₹129,611.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,914.20 | ₹31,658,982,513.00 | ₹9,690.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹279.30 | ₹28,008,903,926.00 | ₹39,032.00 |
Key Executives
Chief Marketing Officer
Mani Bhagavatheeswaran
Gender: male
Year Born:
Chief Financial Officer
N. Swaminathan
Gender: male
Year Born:
Chief Sales Officer
R. Narayanan
Gender: male
Year Born:
Executive Chairman & MD
Sambhu Prasad Sivalenka
Gender: male
Year Born: 1974
Chief Operating Officer of Supply Chain & Product Delivery
S. Jeyakanth
Gender: male
Year Born:
Compliance Officer & Company Secretary
Gagan Preet Singh
Gender: male
Year Born:
FAQs about Amrutanjan Health Care Limited
Who is the CEO of the company?
The CEO is Sambhu Prasad Sivalenka.
What is the current market price of the stock?
The current price is ₹600.05.
What is the 52-week price range?
The range is ₹544.1-790.95.
What is the market capitalization of the company?
The market capitalization is ₹1,734.15 crores.
What is the dividend yield?
The dividend yield is 0.77%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 30.48.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Amrutanjan Health Care Limited (ISIN: INE098F01031) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹1,734.15 crores and an average daily volume of 13,205 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹4.6.